141 related articles for article (PubMed ID: 24098950)
1. An improved radiolabelled RNA aptamer molecule for HER2 imaging in cancers.
Varmira K; Hosseinimehr SJ; Noaparast Z; Abedi SM
J Drug Target; 2014 Feb; 22(2):116-22. PubMed ID: 24098950
[TBL] [Abstract][Full Text] [Related]
2. A HER2-targeted RNA aptamer molecule labeled with 99mTc for single-photon imaging in malignant tumors.
Varmira K; Hosseinimehr SJ; Noaparast Z; Abedi SM
Nucl Med Biol; 2013 Nov; 40(8):980-6. PubMed ID: 23953624
[TBL] [Abstract][Full Text] [Related]
3. An improved
Khodadust F; Ahmadpour S; Aligholikhamseh N; Abedi SM; Hosseinimehr SJ
Eur J Med Chem; 2018 Jan; 144():767-773. PubMed ID: 29291444
[TBL] [Abstract][Full Text] [Related]
4. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
Ortiz-Arzate Z; Santos-Cuevas CL; Ocampo-García BE; Ferro-Flores G; García-Becerra R; Estrada G; Gómez-Argumosa E; Izquierdo-Sánchez V
Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877
[TBL] [Abstract][Full Text] [Related]
5. Tricine co-ligand improved the efficacy of
Shaghaghi Z; Abedi SM; Hosseinimehr SJ
Biomed Pharmacother; 2018 Aug; 104():325-331. PubMed ID: 29775901
[TBL] [Abstract][Full Text] [Related]
6. In vitro evaluation of (99m)Tc-EDDA/tricine-HYNIC-Q-Litorin in gastrin-releasing peptide receptor positive tumor cell lines.
Yurt Lambrecht F; Durkan K; Ozgür A; Gündüz C; Avcı CB; Susluer SY
J Drug Target; 2013 May; 21(4):383-8. PubMed ID: 23301856
[TBL] [Abstract][Full Text] [Related]
7. Tumor targeting with a (99m)Tc-labeled AS1411 aptamer in prostate tumor cells.
Noaparast Z; Hosseinimehr SJ; Piramoon M; Abedi SM
J Drug Target; 2015; 23(6):497-505. PubMed ID: 25673264
[TBL] [Abstract][Full Text] [Related]
8. Comparative assessment of a
Torabizadeh SA; Abedi SM; Noaparast Z; Hosseinimehr SJ
Bioorg Med Chem; 2017 May; 25(9):2583-2592. PubMed ID: 28351606
[TBL] [Abstract][Full Text] [Related]
9. Monitoring therapeutic response of human ovarian cancer to trastuzumab by SPECT imaging with (99m)Tc-peptide-Z(HER2:342).
Zhang J; Zhao X; Wang S; Wang N; Han J; Jia L; Ren X
Nucl Med Biol; 2015 Jun; 42(6):541-6. PubMed ID: 25735223
[TBL] [Abstract][Full Text] [Related]
10.
Ahmadpour S; Noaparast Z; Abedi SM; Hosseinimehr SJ
J Biomed Sci; 2018 Feb; 25(1):17. PubMed ID: 29455647
[TBL] [Abstract][Full Text] [Related]
11. 99mTc-labeling and in vitro and in vivo evaluation of HYNIC- and (Nalpha-His)acetic acid-modified [D-Glu1]-minigastrin.
von Guggenberg E; Behe M; Behr TM; Saurer M; Seppi T; Decristoforo C
Bioconjug Chem; 2004; 15(4):864-71. PubMed ID: 15264875
[TBL] [Abstract][Full Text] [Related]
12. 99mTc-labeling of HYNIC-conjugated cyclic RGDfK dimer and tetramer using EDDA as coligand.
Wang J; Kim YS; Liu S
Bioconjug Chem; 2008 Mar; 19(3):634-42. PubMed ID: 18281926
[TBL] [Abstract][Full Text] [Related]
13. [Comparative study of the biodistribution of (99m)Tc-HYNIC-Lys3-Bombesin obtained with the EDDA/tricine and NA/tricine as coligands].
Hernández-Cairo A; Perera-Pintado A; Prats-Capote A; Batista-Cuellar JF; Casacó-Santana C
Rev Esp Med Nucl Imagen Mol; 2012; 31(2):61-5. PubMed ID: 22305264
[TBL] [Abstract][Full Text] [Related]
14. [99mTc] HYNIC-hEGF, a potential agent for imaging of EGF receptors in vivo: preparation and pre-clinical evaluation.
Babaei MH; Almqvist Y; Orlova A; Shafii M; Kairemo K; Tolmachev V
Oncol Rep; 2005 Jun; 13(6):1169-75. PubMed ID: 15870939
[TBL] [Abstract][Full Text] [Related]
15.
Masteri Farahani A; Maleki F; Sadeghzadeh N; Abediankenari S; Abedi SM; Erfani M
Chem Biol Drug Des; 2020 Aug; 96(2):850-860. PubMed ID: 32279449
[TBL] [Abstract][Full Text] [Related]
16. In vitro cell studies of technetium-99m labeled RGD-HYNIC peptide, a comparison of tricine and EDDA as co-ligands.
Su ZF; He J; Rusckowski M; Hnatowich DJ
Nucl Med Biol; 2003 Feb; 30(2):141-9. PubMed ID: 12623113
[TBL] [Abstract][Full Text] [Related]
17. Preliminary application of micro-SPECT/CT imaging by
Zhang Y; Meng L; Li B; Tan H; Lin QY; Cheng D; Shi H
Chem Biol Drug Des; 2019 Apr; 93(4):447-453. PubMed ID: 30381892
[TBL] [Abstract][Full Text] [Related]
18. Formulation and Preclinical Testing of Tc-99m-Labeled HYNIC-Glc-FAPT as a FAP-Targeting Tumor Radiotracer.
Yang X; Li G; Ruan C; Hu K; Tang G
Bioconjug Chem; 2023 Nov; 34(11):2133-2143. PubMed ID: 37874952
[TBL] [Abstract][Full Text] [Related]
19. Preparation and evaluation of
Gan Q; Song X; Zhang X; Zhang J
Eur J Med Chem; 2020 Feb; 188():112032. PubMed ID: 31926467
[TBL] [Abstract][Full Text] [Related]
20. (99m)Tc-maEEE-Z(HER2:342), an Affibody molecule-based tracer for the detection of HER2 expression in malignant tumors.
Tran T; Engfeldt T; Orlova A; Sandström M; Feldwisch J; Abrahmsén L; Wennborg A; Tolmachev V; Karlström AE
Bioconjug Chem; 2007; 18(6):1956-64. PubMed ID: 17944527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
